Talk:ELOC-mutated renal cell carcinoma

From Libre Pathology

Revision as of 16:27, 6 March 2025 by Michael (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931622/ cyclin D1, beta-catenin ???

https://pubmed.ncbi.nlm.nih.gov/31748879/ cyclin D1 +ve subset of ccRCC has favourable prognosis

https://pubmed.ncbi.nlm.nih.gov/35653922/

Antibodies

https://www.antibodies.com/products/primary-antibodies/tceb1-antibodies

Retrieved from "https://librepathology.org/w/index.php?title=Talk:ELOC-mutated_renal_cell_carcinoma&oldid=53460"